| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥2.25B | -5.0% |
| Gross profit | ¥0.66B | — |
| Operating income | ¥0.16B | — |
| Net income | ¥0.10B | +2397.8% |
| Gross margin | 29.5% | Net margin 4.6% |
| Revenue Q/Q | -11.2% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.58B | 70.5% |
| R&D | ¥0.05B | 2.3% |
| SG&A | ¥0.38B | 16.8% |
| Tax & other | ¥0.05B | 2.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
ST天玑 ・ 宝莱特 ・ 融捷健康 ・ 新开普 ・ 依米康 ・ 初灵信息 ・ 金信诺 ・ 卫宁健康 ・ 仟源医药 ・ 常山药业 ・ 星星科技 ・ 开山股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies